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provided us with new knowledge of the field as well as a greater understanding of the 
scientific method. 
  
 
II 
 
 
 
 
A Population-Based Study on Health Anxiety and Disability 
Pension Award: The HUSK Study  
OVE HERADSTVEIT AND KARI ERIKSEN 
 
From the Faculty of Psychology, Research center for Health Promotion, University of 
Bergen, Norway (O.H., K.E.) 
Address correspondence and reprint requests to Ove Heradstveit, University of 
Bergen, Christiesgt 13, N-5015 Bergen, Norway. E-mail: Ove.Heradstveit@student.uib.no 
 
  
 
III 
 
 
 
 
ABSTRACT 
Objective: Studies exploring functional impairments in health anxiety are almost 
exclusively cross-sectional, and mainly carried out in clinical settings. As most cases never 
find their way into psychiatric treatment, our knowledge on the long-term prognosis of health 
anxiety as it occurs in the general population is limited. We aimed to study the long term 
prognosis of health anxiety by employing subsequent disability pension award as a measure of 
global functioning.  Methods: Using a historical cohort design, we utilized a unique link 
between a large epidemiological cohort study and a comprehensive national database. 
Information on disability benefit recipiency was obtained from Norwegian registry data, and 
merged with health information, including health anxiety and a range of potential 
confounders, from the Hordaland Health Study (HUSK) in Western Norway, 1997–99. 
Participants (N = 6819) were aged 40-46 at baseline, and the mean time of follow-up after 
participation was 3.6 years. Results: Health anxiety was a strong independent risk factor for 
subsequent disability pension award. This effect was only partly accounted for by adjusting 
for gender, socio-demographic variables, somatic conditions, anxiety, depression and somatic 
symptoms. The increased risk of health anxiety on disability pension award was not only 
observed at the highest symptom levels. There was also a significant dose-response 
association. Conclusions: Health anxiety is associated with subsequent long-term work-
related disability. The true effect of health anxiety on disability pension award appears to be 
underestimated in official registries. 
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INTRODUCTION 
Hypochondriasis is classified as a somatoform disorder in which there is an excessive 
concern for one's own health. This is coupled with the belief that one has an undiagnosed 
physical illness, which persists despite adequate reassurance from medical staff (1). A range 
of disabling consequences is found to by associated with hypochondriasis (2), among them 
impaired physical health (3), more health worries, psychiatric symptoms (4) and medically 
unexplained symptoms (3), an above average utilization of health service (5) higher health 
care costs (6), and occupational disability (5). However, the studies demonstrating this are 
almost exclusively cross-sectional, making casual assumptions more difficult.  
Generally, the findings in primary care settings indicate that the full syndrome of 
hypochondriasis according to diagnostic criteria is relatively uncommon, however, prevalence 
rates are conflictual, ranging from 0.2 to 8.5% (2, 7). It has been argued that the present ICD-
10 and DSM-IV definitions of hypochondriasis are highly restrictive (5, 7). As a consequence, 
attempts have been made to define and validate an abridged form of hypochondriasis (5, 7). In 
addition to concepts of abridged hypochondriasis, the term ‘health anxiety’ was 
conceptualized on a continuum ranging from mild to severe (8) with hypochondriasis being at 
the severe end of the continuum (9). Such less restrictive conceptualizations of 
hypochondriasis are relatively prevalent, with estimates ranging from 2 to 9% (3, 5), and are 
related to considerable psychological and physical impairment (10). A large community-based 
study even indicate that patients with the full syndrome of hypochondriasis were no more 
disabled than those with less extreme health anxiety symptoms (5). This suggests that health 
anxiety below the diagnostic threshold of hypochondriasis should be included into clinical 
and scientific consideration.  
Comorbidity with other psychiatric disorders is common in hypochondriasis: 62% (11) 
to 88% (12) in this patient group presents with at least one additional psychiatric disorder. 
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The differentiation and association between commonly comorbid mental disorders are 
generally debated. Somatization disorder (e.g. 13) and other anxiety disorders (e.g. 14) are the 
most commonly reported comorbid conditions to hypochondriasis. The boundaries between 
the disorders have consequently been subject to scientific discussion (15, 16). However, the 
question persists whether hypochondriasis represent a distinct nosological category. No 
studies have to our knowledge examined the extent to which health anxiety is related to 
disability when controlling for comorbid conditions. 
Several theoretical and empirical attempts have been made to distinguish different 
conceptual dimension of hypochondriasis (e.g. 17). A particularly common approach is the 
three components proposed by Pilowsky (18): ‘disease phobia’, ‘disease conviction’, and 
‘bodily preoccupation’. Research has mainly focused on validating the factors by exploring 
internal validity and external validity in terms of case-finding properties (e.g. 19). To our 
knowledge no studies have examined how the different conceptual dimensions are related to 
functional impairment.  
Disability benefit awards are likely to be a valid measure of functional impairment 
related to mental disorders, as loss of ability to work is among the functional disabilities 
generally associated with psychopathology (20). 
In the present study we aim to study the effect of health anxiety on subsequent 
disability pension awards in the context of a population-based health survey. More 
specifically we aim to study the following questions:  
- Is there an independent effect of health anxiety on subsequent disability pension 
award?  
- Is the eventual effect of health anxiety on subsequent disability pension award 
exclusive to the very highest symptom levels? 
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- Is health anxiety officially recognized as cause of disability pension award in official 
statistics and clinical practice? 
- How strong is the effect size of health anxiety on subsequent disability pension award 
compared to other mental disorders? 
- Are the three components of health anxiety; ‘bodily preoccupation’, ‘disease phobia’ 
and ‘disease conviction’, all related to subsequent disability pension award? 
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METHODS 
Study Design 
This historical cohort study used mental and somatic health data obtained from the  
Hordaland Health Study (HUSK). HUSK was a joint epidemiological research project carried 
out from 1997 to 1999 by the National (Norwegian) Health Screening Service in collaboration 
with the University of Bergen. Disability pension award over a 6.6 years follow-up period 
after baseline assessment were obtained from the National Insurance Administration and were 
linked to the HUSK Study data using the national identity number. The study design is 
inspired by previous publications linking national epidemiological cohort studies to data from 
the National Insurance Administration (21-23).   
 
Participants and Procedures 
The base population included 29 400 individuals in Hordaland County in western 
Norway born 1953 to 1957, aged 40 to 47 at the time of the data collection. Data were 
collected by questionnaires and clinical examinations. A total of 18 581 (8 598 men and 9983 
women) answered both the first questionnaire and attended the clinical examinations, yielding 
a participation rate of 63% (57% for men and 70% for women). Upon attending the clinical 
examinations, a second questionnaire including the Whiteley Index was distributed to a 
random 50% of the participants and prompted for return by mail. A total of 7274 individuals 
(3779 men and 3495 women) returned this. HUSK responders who were receiving a disability 
pension award at baseline or who were granted a disability pension award within 12 months 
after baseline were excluded (N=277). Valid responses to Whiteley Index, HADS general 
anxiety, HADS depression and somatic symptoms questionnaires were set as inclusion criteria 
for our study population. All individuals lacking information on either of these variables were 
excluded (N=178). Individuals lacking information on number of somatic diagnosis (N=13), 
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number of drugs taken for any somatic condition (N=111) and household income (N=221) 
were given the mean values of the total population on the respective variables (missing 
substitution). After exclusion, the study population consisted of 6819 persons (3569 men and 
3250 women), yielding a final response rate of 46%. 
 
Exposure: Health Anxiety 
Health anxiety was assessed with the 14-item self-report questionnaire Whiteley Index 
(18), which is one of the most widely used hypochondriasis screening instruments (24). 
Whiteley Index is designed to assess core features of health anxiety. Its validity, reliability, 
and sensitivity to change have been well demonstrated (e.g. 25). Each of the 14 items 
describes symptoms of health anxiety, and participants were asked to rate how true these 
descriptions were for them on a 5 point likert scale labelled; ‘Not at all, to some extent, 
moderately, to a considerable extent, to a great extent’.  
In our study the Whiteley Index is used both as a continuous variable with higher 
scores reflecting increasing symptom load, and as a categorical variable based on a 95th 
percentile cut-off. Scores above cut-off are further referred to as ‘case-level’. The cut-off is 
arbitrary chosen and is not intended to be a proxy for a DSM-IV or ICD-10 defined 
hypochondriasis diagnosis. However, it is likely that the continuum of health anxiety overlap 
with the diagnosis of hypochondriasis in the highest percentiles (9). 
The Whiteley Index has been used mainly as a full scale (e.g. 26) in clinically based 
research, but in the original version it includes three different subscales (18): ‘disease phobia’, 
‘bodily preoccupation’, ‘disease conviction’. We both use the full scale as exposure measure, 
and do also include some additional analyses of the subscales.  
 
Outcome: Disability Pension Awards 
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The outcome variable was award of a disability pension 1.0 – 6.6 years after 
participation in HUSK. By excluding all disability pensions awarded 0 – 12 months after 
participation in the health survey, we aimed to exclude subjects in the process of applying for 
a disability pension award while they attended HUSK, thus reducing any possible protopathic 
bias (22). The mean time of follow-up for those receiving a disability pension award was 3.6 
years after the health survey (S.D. = 1.5 years). 
Information on benefits was confirmed from the National Insurance Administration 
and was merged to the health survey by Statistics Norway through the national identification 
number. The National Insurance Administration records all grants of disability pension award, 
which, in Norway, is a public responsibility. Correct registration is a prerequisite for transfers 
of payments; thus, the records are highly accurate.  
The National Insurance Administration records one or two diagnoses, primary and 
secondary diagnosis warranting disability pension award for every application. Diagnoses 
were encoded according to ICD-10. We use the primary diagnose for every application in our 
analyses. Diagnoses were used to identify disability pension awarded for any mental disorder 
(F00 – F99), for any anxiety disorder diagnoses (F40 – F48), and for any musculoskeletal 
diagnoses (M00 – M99). 
 
Mediators and Confounders  
General anxiety and depression symptoms were assessed with the Hospital Anxiety 
and Depression Scale (HADS), which contain seven items each on cognitive symptoms of 
general anxiety and depression (27). In a recent literature review, HADS has demonstrated 
good case-finding properties for anxiety and depression in both primary care and hospital 
settings (28). In our study HADS-scores are used as continuous variables, with increasing 
levels reflecting higher and 	
symptom load. 
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Questions on somatic diagnoses were framed in the form of: ‘Do you have or have you 
had (one of the following)’, coronary infarction, stroke, diabetes, asthma, multiple sclerosis, 
chronic bronchitis, osteoporosis, or fibromyalgia. Numbers of positive responses to these 
items produces a continuous variable of self-reported diagnoses (somatic diagnoses). In 
addition, participants were asked if they used any medication the previous day, and if so, for 
which condition. From these responses, a team of physicians appointed appropriate ICPC-
diagnoses according to 	
		, producing a continuous variable indicating 
number of somatic conditions for which the person is taking medication (drugs taken for any 
somatic condition). 
Participants were also asked to rate the frequency of 17 common symptoms from 
different organ systems in accordance with the ICD-10 Research Criteria for F45 Somatoform 
Disorders (29) on a five point likert scale labelled: ‘Almost never, rarely, sometimes, often 
and almost always’. The items were summed and comprise the continuous variable somatic 
symptoms. This variable is an indicator both of somatic health with increasing levels 
reflecting higher symptom load, and mental health with higher scores reflecting an increased 
tendency towards somatization. After adjustment for somatic conditions, we are interpreting 
higher scores of this variable as somatization. Total symptom scores are often used in both 
research and clinical practice to determine severity levels, especially for mental health 
conditions. Higher scores reflect more health problems. 
 Information on gender and age at the time of the HUSK study was obtained from the 
national population registry. Self-reported annual household was measured by one 
item and coded in nine categories from no income to more than NOK 500 000 (approximately 
60 000). Level of 	was reported in four categories from less than seven years of 
schooling up to 4 years or more of higher education in college/university.  
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Statistics 
To explore whether there was an independent effect of health anxiety on subsequent 
disability pension award we used a logistic regression analysis. In this paper, results are 
presented as odds ratios with 95 percent confidence intervals. Blocks of variables were 
entered sequentially in an a priori determined order, and finally in a fully adjusted model. 
Gender, income and education were entered first. Thereafter somatic conditions (somatic 
diagnoses and drugs taken for any somatic condition) were entered, as it was presumed to be 
an important cause of disability benefits, and to avoid overestimating subsequent effects of 
anxiety, depression and somatic symptoms. Anxiety and depression were entered separately 
because we were interested in their unique contribution as confounding factors. The somatic 
symptoms variable was entered last as it might be a product of either somatic conditions or 
anxiety and depression. This procedure was done with both continuous and categorical health-
anxiety variables. We also made a combination variable of health anxiety and somatization, to 
examine the unique and combined contribution of somatization. The variable included four 
levels: neither health anxiety nor somatization, somatization only, health anxiety only, and 
comorbid somatization and health anxiety; all based on a 90th percentile cut-off. This variable 
was further used as a predictor variable in the same hierarchal model.   
To explore whether the effect of health anxiety on subsequent disability pension award 
was exclusive to the very highest symptom levels, as opposed to being a dose-response 
association applying to the whole scale, we coded the continuous health anxiety variable into 
deciles. This was plotted against percentage awarded disability pension award during follow 
up. Results are presented with 95% confidence interval. Pearson correlation coefficient was 
used to test the linearity of the relationship.  
To determine to what extent health anxiety was officially recognized as cause of 
disability pension award in official statistics and clinical practice, the logistic regression 
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model described above was carried out equivalently for three nested outcomes; the subsequent 
award of 1) any disability pension, 2) disability pension excluding those justified by an 
anxiety disorder and 3) disability pension excluding those justified by any mental disorder. 
We also checked whether any of the individuals participating in the study was awarded a 
disability pension for the specific cause of hypochondriasis in official statistics. In addition, 
the Pearson chi-square test was used to compare the causes of permanent work disability in 
case-level and non case-level health anxiety.  
To determine the relative strength of the effect of health anxiety on subsequent 
disability pension award compared to other mental disorders, we did separate logistic 
regression analyses with the HADS general anxiety and depression variables as predictor 
variables (continuous scores). 
To explore whether the three components of health anxiety; ‘bodily preoccupation’, 
‘disease phobia’ and ‘disease conviction’, all were related to subsequent disability pension 
award, exploratory principal component analysis was conducted on the items of the Whiteley 
Index, using the Kaiser criterion to determine the number of factors, where only factors whose 
eigenvalues are larger than 1 are considered as being of interest. Logistic regression analysis 
was used to examine the relation between each of the factors of interest and the outcome of 
subsequent disability pension award.  
 
Ethics 
The study protocol was approved by the Regional Committee for Medical Research 
Ethics, Western Norway and by the Norwegian Data Inspectorate. 
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RESULTS 
The baseline characteristics of the 6819 persons who completed the Whiteley Index 
questionnaire are shown in table 1. Health anxiety was equally prevalent among men and 
women. It was more prevalent among persons with lower educational levels and lower 
household income. Self-reported somatic symptoms, anxiety and depression were all strongly 
associated with health anxiety, whereas number of somatic diagnoses was not. 
Health anxiety was associated with a significantly elevated risk (OR 1.76, 95% CI: 
1.60 – 1.94) for subsequent disability pension award during follow up (table 2, left column). 
Similar results were found for the cut-off based scores (table 3, left column). This effect was 
only slightly attenuated after adjustment for gender, education and income, and somatic 
conditions. Further adjustment for HADS general anxiety and depression reduced the effect 
moderately. Adjusting for somatic symptoms explained a substantial part of the effect, 
although the effect of health anxiety remained highly significant. There was an increased risk 
of disability pension award in comorbid cases of health anxiety and somatization (table 4). 
However, there was no interaction effect between the two disorders on award of disability 
pension, so the higher risk in the comorbid group was merely an additive effect. 
There was a dose-response association (r=.114, p<.001) between levels of health 
anxiety and subsequent award of disability pension during follow-up (figure 1). The 
association was stronger in the two last than in the eight first deciles. However, the dose-
response association was still highly significant (r=.046, p.001) within the eight first deciles. 
Several findings indicate an underestimation of the effect of health anxiety in official 
statistics and clinical practice. First, the effect of health anxiety on subsequent disability 
pension award, when excluding those justified by any anxiety disorder diagnostic code, as 
well as by any mental disorder diagnostic code, was as strong as for the award of disability 
pension in general (table 2 and 3, right column). Second, even if there was a tendency that 
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more disability pensions were awarded for mental disorders in case-levels, there was no 
significant difference in official causes of disability pension award between case-level health 
anxiety and non case-levels (table 5). Last, no disability pensions were awarded for the 
specific cause of hypochondriasis. 
The effect of health anxiety on the outcome of subsequent disability pension award 
was on level with that of both HADS depression (OR 1.58, 95% CI: 1.42 – 1.76) and HADS 
general anxiety (OR 1.55, 95% CI: 1.38 – 1.74) (table 6). 
Factor analysis of the Whiteley Index revealed three factors similar to the original 
scales proposed by Pilowsky (18) (Table 7). The subscales of ‘bodily preoccupation’ and 
‘disease conviction’ were significant predictors of subsequent disability pension award, 
whereas the subscale ‘disease phobia’ was not.  
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DISCUSSION 
Summary of Results 
In summary, we found that health anxiety was a strong predictor of subsequent 
disability pension award. The increased risk of health anxiety on disability pension award was 
not only observed at the highest symptom levels; there was also a significant dose-response 
association. Health anxiety appears to be under-recognized as cause of disability pension 
award in official statistics and clinical practice. The effect of health anxiety on subsequent 
disability pension awards was on level with that of depression and general anxiety. As 
depression is the most important mental diagnosis causing disability pension award (30), this 
clearly demonstrates the importance of our findings.  
Population-based studies on health anxiety and hypochondriasis are specifically called 
for in recent scientific work (2). Our study is the first using a prospective population-based 
design to show long-time adverse effects of health anxiety on work-related disability.  
 
Strength and Limitations  
The present study has several strengths mainly arising from the cohort design. The 
study sample was large, and the participation rate at baseline was high. Both exposure and 
outcome assessments should be relatively unbiased. At baseline measurement, neither 
participants nor administrators were aware of the specific research hypotheses, reducing the 
possibility of information being biased by selective symptom presentation in order to gain 
access to, or avoid, benefits. Ascertainment of disability pension award status at baseline and 
at follow-up was obtained from the National Insurance Administration. These data are 
complete (including those moving to other parts of the country and those claiming disability 
benefits living abroad) and should not have been influenced by exposure status. The study 
covers somatic conditions, mental health and somatic symptoms that encompass the most 
  
13 
 
 
 
prevalent diseases and illnesses in benefit recipiency, as well as socio-economic variables 
relevant for both health and benefit recipiency (31). The included age span is highly relevant 
as participants potentially have a number of years left as members of the work-force, and the 
population was drawn from the general population in a representative area with both urban 
and rural communities. 
There are several limitations of our study. First, the response-rate was relatively low, 
and it is generally assumed that there are some important differences between attenders and 
non-attenders in epidemiologic studies. The rate of disability pension award was higher 
among the non-attendees in the HUSK study (21). This could cause an underestimation of the 
true differences between the groups. However, non-responders are usually more functionally 
limited, and it is commonly held that serious psychopathology increases the risk of being a 
non-attendee in epidemiologic studies (32). In the specific case of hypochondriasis this might 
however not be the case. As preoccupation with health-related issues is a core feature of the 
disorder, it is possible that hypochondriacs will be more willing to attend a health screening. 
We can not exclude systematic bias in any direction. However, the associations are very 
unlikely to be products of eventual biases.  
Second, there are some limitations regarding our measurement of health anxiety. Data 
are based on self-report rather than clinical examination. Misclassification is likely to have 
been random resulting in an underestimation of the true association, but bias cannot be 
excluded. Also, our case-level analyses are based on a non-validated, and therefore arbitrary, 
cut-off. However, these analyses were only supportive to the main analyses which were based 
on continuous scores. In addition, analyses based on alternative cut-offs yielded similar 
results.   
Third, we interpret higher scores on the somatic symptoms variable as somatization, 
but cannot fully exclude that the reported symptoms are symptoms of undiscovered somatic 
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illnesses. However, our study population is relatively young (40-47 years at the time of data 
collection), reducing this possibility.   
Fourth, the list of symptoms and conditions is not complete. Residual confounding 
from chronic somatic, psychosomatic or psychiatric conditions can therefore not be excluded. 
More specifically, the impacts of psychoses or other serious psychiatric conditions are not 
captured.  
Fifth, our health anxiety index is more expansive than the measure of general anxiety. 
It is thus possible that our health anxiety index is more sensitive to general anxiety than our 
measure of general anxiety itself, possibly causing an under-estimation of the true effect of 
general anxiety.  
Sixth, information on somatic diagnoses and symptoms was self-reported, and the 
categories used were not exhaustive. If such diagnoses and symptoms were underreported, the 
effects of health anxiety may in turn have been overestimated. However, in our fully adjusted 
model, health anxiety was considered to predict disability pension award only if reported 
somatic diagnoses, somatic symptoms, anxiety, or depression did not serve as a possible 
explanation. Because this model assumed that health anxiety was secondary in all instances of 
simultaneous occurrences, it is likely that we underestimated the strength of the association of 
health anxiety with later disability pension award in the fully adjusted models.  
Seventh, the number of diagnoses reported by general practitioners on any application 
for disability pension award is limited to two; one primary diagnosis and one secondary 
diagnosis. As we are using only the primary diagnosis in our analyses there is a possibility 
that we ignore mental disorders reported as secondary diagnoses. This might have led to an 
underestimation of the degree to which health anxiety are recognized in official registries. 
Further, as general practitioners are limited to report two diagnoses, they might have intended 
to report mental diagnoses but were hindered by the restriction to number of diagnoses. We 
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do however believe this to be a limited problem since previous studies on the same data 
material have found that mental diagnoses when used, commonly were reported as primary 
diagnoses (22). 
Eighthwe are intending to control for potential confounders to establish whether or 
not there is an independent association between health anxiety and subsequent disability 
pension awards. Confounders are defined as variables which are causally related to the 
outcome, but are not on a causal pathway between exposure and outcome. Confounding 
occurs only where an association between a presumed causal variable and a presumed 
outcome is accounted for by a common cause not in the postulated causal pathway. Thus, if 
some of the factors we are adjusting for in our model lie on the causal pathway from health 
anxiety to award of disability pension, we are over-adjusting. In our model somatic symptoms 
and anxiety poses particular challenges as their association and differentiation to health 
anxiety are not yet fully understood. However, the most conservative way to deal with such an 
unresolved question regarding the nature of the relationship between the variables is to adjust 
for it.  
Regarding the study’s generalizability, the disability pension schemes in Norway are 
similar to other OECD countries, and similar secular increases in the proportion of inflow 
cases justified by psychiatric diagnoses have been reported (33). However, disability 
expenditures constitute a greater part of the gross domestic product (GDP) in Norway than in 
most other OECD countries (34). 
 
	

Our findings have noteworthy implications on several domains, including the 
management of employment issues in dealing with health anxiety and mental disorders in 
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general, the need for a broader concept of hypochondriasis, and the boundaries between health 
anxiety and related disorders.  
First, our findings have implications for the societal management of health anxiety. 
According to official registries, mental disorders account for 30% of all disability pensions 
awarded in Norway (35). However, studies suggest that the true impact of mental disorders in 
this regard is considerably underestimated (22). Several of the results in the present study, 
indicate that this also might be the case for health anxiety. Most important, disability pensions 
in cases of health anxiety were neither awarded for other ICD-10 anxiety disorder diagnoses 
nor for other mental disorders. Even if the assigned somatic causes are both accurate and 
relevant, they might not constitute the whole clinical picture.  
There are several plausible explanations for mental disorders being under-estimated as 
causes to disability pensions. General practitioners (GP) might be hesitant to report mental 
diagnoses on the application for disability pension when the patient presents with diffuse 
somatic symptoms (21). Also, there is a possibility that the underlying psychopathology is not 
detected by the GPs. Further, GPs are supposed to apply diagnostic criteria strictly and not 
report subsyndromal conditions. This is problematic as considerable impairment results from 
subsyndromal cases of mental disorders (36). 
The current under-estimation of mental disorders in general and health anxiety 
specifically as causes to disability pension award has several negative implications. As 
official registries guide political priorities and allocations, under-estimation might lead to 
political neglect in addressing the problem. Also, the overall costs of work disability are high, 
both to employees and employers, and to the society as a whole (37, 38). This should 
encourage a re-examination of the effectiveness of measures addressing the employment 
issues of people with mental disorders, and point to the need to take appropriate measures in 
the public health management of the disorder.  
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Until recently, no specific treatment of hypochondriasis and health anxiety was clearly 
demonstrated to be effective. However, several reviews conclude that both relatively brief 
individual cognitive-behavioral therapy (CBT) (39) and pharmacological treatments with 
selective serotonin reuptake inhibitors (SSRIs) (40) constitute effective treatments of 
hypochondriasis.  
However, most likely the majority of health anxiety cases are not offered any 
treatment, as mental health problems are generally reported to be under-treated (41). Further, 
it is reason to believe that the available treatment not necessarily represent ‘state-of-the-art-
treatment’, as the process of integrating scientifically based treatment guidelines has been 
proven to be difficult (42). Whether and to which degree persons entering the disability 
benefit system have had access to appropriate treatment is also questioned (43). Recent 
studies therefore suggest that there is a potential for preventing permanent work-related 
disability through improved access to effective treatment (44, 45). Even if there currently is 
no research available on under-treatment of health anxiety before awarding of disability 
pension, there is reason to believe that treatment is underutilized also here.  
Second, the increased risk of health anxiety on subsequent disability awards was not 
only observed at the very highest symptom levels. There was also a significant dose-response 
association. This indicates a disabling impact of health anxiety even at moderately high levels. 
The diagnostic cut-off for hypochondriasis has been questioned in recent research (5, 10, 46, 
47), pointing to a need for a broader concept of hypochondriasis than represented in the 
stochastic diagnostic definitions. Our findings support such notions. However, as opposed to a 
recent finding indicating that subsyndromal hypochondriasis is as disabling as full blown 
hypochondriasis (5), our results clearly indicate that the highest symptom levels is associated 
with most pronounced impairment.  
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Third, somatization and anxiety constitute particular challenges to the question of 
whether there is an independent effect of health anxiety on subsequent disability pension 
award, as the boundaries between the disorders are debated (15, 16). Our study does not 
represent a solution to the ongoing debates of whether health anxiety is a distinct category or 
overlapping with either somatization or anxiety. However, by examining the consequences of 
the disorders on work-related disability our study adds some knowledge to the question.  
The somatizing component of health anxiety, as measured by the subscale of ‘bodily 
preoccupation’ (e.g. 24), was the strongest predictor of subsequent disability pension award. 
On this basis, one might suggest that the effect of health anxiety on the outcome is mainly an 
effect of somatization. In accordance with this interpretation, somatic symptoms per se 
explained a substantial part of the variance on disability pension award in all our statistical 
models. However, even after adjusting for somatic symptoms, the effect of health anxiety 
remained highly significant. Also, the subscale of ‘disease conviction’ was an independent 
risk factor for subsequent disability pension award. This factor has been suggested to 
represent the cognitive component of the disorder (14, 24) and is supposedly independent 
from the aspect of somatization. When it comes to anxiety, our findings indicate that the 
effect of health anxiety is not merely an effect of general anxiety. Adjusting for general 
anxiety does not substantially change the effect of health anxiety on the outcome. General 
anxiety is also not an independent risk factor for subsequent disability pension award in our 
models.   
Thus, the disabling impact of health anxiety is clearly not fully explained by neither 
somatization nor general anxiety. This can be seen as a support of the conceptualization of 
health anxiety as a distinct disorder as opposed to both somatization and anxiety. 
 
Conclusion 
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Health anxiety is associated with considerable work-related disability. Given the 
strong adverse consequences of work disability, this should on a policy level encourage 
considerations of increased involvement of mental health specialists in treatment before 
disability pensions are awarded. These considerations should not be limited to the full 
syndrome of hypochondriasis, but also apply to health anxiety below the diagnostic threshold 
of hypochondriasis. On the other hand, eventual initiatives to increase the accessibility and 
quality of treatment will have to rest upon on thorough cost-efficacy considerations.  
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Tables 
Table 1. Baseline demographic and clinical characteristics of persons who completed the Whiteley Index 
questionnaire in the Hordaland Health Study (N = 6819) 
 
Characteristic Hypochondriasis score  
< 95 percentile  
Hypochondriasis score 
 >= 95 percentile  
Group differences 
N (% of sample) 6542 (95.9) 277 (4.1)  
Gender, N (%) 
  Female 
 
3122 (47.7) 
 
128 (46.2) 
Chi-sq=.244, df=1, p=.621 
Education, N (%) 
  Primary  
  Secondary  
  1–3 yr higher  
  4 yr higher  
 
1090 (16.7) 
3041 (46.5) 
1299 (19.9) 
1112 (17.0) 
 
68 (24.5) 
117 (42.2) 
47 (17.0) 
45 (16.2) 
Chi-sq=11.981, df=3, p<.01 
Income, N (%) 
  75 000 
  125 000 
  175 000 
  250 000 
  350 000 
  450 000 
  500 000 
 
109 (1.7) 
165 (2.6) 
386 (6.1) 
1304 (20.6) 
1336 (21.1) 
1394 (22.0) 
1640 (25.9) 
 
20 (7.6) 
13 (4.9) 
23 (8.7) 
69 (26.1) 
47 (17.8) 
49 (18.6) 
43 (16.3) 
Chi-sq=67.891, df=6, p<.001 
Anxiety1  4.38 (4.31 – 4.46) 9.10 (8.62 – 9.58) F=48.301, df=6817, p<.001 
Depression1 3.09 (3.02 – 3.16) 6.73 (6.27 – 7.19) F=91.851, df=6817, p<.001 
Number of somatic 
diagnoses1 
0.08 (0.07 – 0.09) 0.11 (0.07 – 0.15) F=12.116, df=6804, p=.073 
Number of self-
reported somatic 
symptoms1  
10.69 (10.50 – 10.87) 20.82 (19.71 – 21.92) F=21.752, df=6817, p<.001 
1
 values are expressed as means (95% confidence interval). 
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 Table 2. Effect of health anxiety (continuous z-scaled score) on risk of disability pension award (N = 6819) 
 
Adjustment variables Full sample 
(N = 227 awards) 1 
Disability pensions 
awarded for anxiety 
disorders excluded 
(N = 212 awards) 1 
Disability pensions 
awarded for any 
mental disorder 
excluded 
(N = 177 awards) 1 
  
OR 
 
 
95% CI 
 
OR 
 
95% CI 
 
OR 
 
95% CI 
Crude  1.76 1.60 – 1.94 1.72 1.55 – 1.89 1.68 1.51 – 1.88 
+ Gender 1.76 1.60 – 1.94 1.71 1.55 – 1.89 1.68 1.50 – 1.87 
+ Income and education  1.66 1.50 – 1.83 1.62 1.46 – 1.79 1.59 1.42 – 1.78 
+ Somatic Conditions2  1.64 1.48 – 1.81 1.60 1.44 – 1.78 1.58 1.41 – 1.77 
+ HADS general anxiety3 1.60 1.42 – 1.81 1.59 1.40 – 1.81 1.68 1.47 – 1.93 
+ HADS depression3 1.55 1.37 – 1.75 1.55 1.36 – 1.76 1.65 1.43 – 1.89 
+ Somatic symptoms3 1.37 1.20 – 1.57 1.36 1.19 – 1.56 1.45 1.25 – 1.68 
1
 N = 6592 not awarded disability pension during follow-up (1.0 to 6.6 years) as a common reference group  
2 somatic diagnosis and drugs taken for any somatic condition 
3 continuous variables 
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Table 3. Effect of health anxiety (case-level >= 95th percentile) on risk of disability pension award (N = 6819) 
 
Adjustment variables Full sample 
(N = 227 awards)1 
Disability pensions 
awarded for anxiety 
disorders excluded 
(N = 212 awards)1 
Disability pensions 
awarded for any 
mental disorder 
excluded 
(N = 177 awards)1 
  
OR 
 
 
95% CI 
 
OR 
 
95% CI 
 
OR 
 
95% CI 
Crude  5.34 3.69 – 7.75 4.73 3.18 – 7.03 4.17 2.66 – 6.54 
+ Gender 5.50 3.78 – 8.00 4.84 3.24 – 7.22 4.25 2.71 – 6.68 
+ Income and education  4.69 3.19 – 6.88 4.15  2.76 – 6.25 3.72 2.35 – 5.90 
+ Somatic Conditions2   4.55 3.09 – 6.70 4.04 2.68 – 6.10 3.65 2.30 – 5.79 
+ HADS general anxiety3 3.42 2.22 – 5.26 3.16 2.00 – 4.99 3.38 2.03– 5.63 
+ HADS depression3 3.05 1.97 – 4.72 2.86 1.80 – 4.53 3.13 1.88 – 5.24 
+ Somatic symptoms3 2.29 1.46 – 3.58 2.12 1.32 – 3.40 2.33 1.38 – 3.94 
1
 N = 6655 not awarded disability pension during follow-up (1.0 to 6.6 years) as a common reference group  
2 somatic diagnosis and drugs taken for any somatic condition 
3 continuous variables 
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Table 4. Effect of health anxiety, somatization, and comorbid health anxiety and somatization (based on a 90th 
percentile cut-off) on risk of disability pension award (N = 6819) 
 
Adjustment variables Health anxiety 
(N = 416) 1 
 
 
OR (95% CI) 
Somatization 
(N = 421) 1 
 
 
OR (95% CI) 
Comorbid health anxiety 
and somatization  
(N = 194) 1 
 
OR (95% CI) 
Crude effect model 3.81 (2.55 – 5.69) 4.53 (3.11 – 6.61) 9.36 (6.19 – 14.17) 
+ Gender 3.87 (2.59 – 5.80) 3.99 (2.72 – 5.85) 8.91 (5.87 – 13.52) 
+ Income and education 3.43 (2.28 – 5.17) 3.46 (2.35 – 5.09) 7.08 (4.63 – 10.84) 
+ Somatic conditions2 3.33 (2.21 – 5.03) 3.20 (2.16 – 4.74) 6.62 (4.31 – 10.18) 
+ HADS general anxiety3 3.13 (2.03 – 4.82) 3.03 (2.02 – 4.56) 5.94 (3.64 – 9.68) 
+ HADS depression3 2.99 (1.94 – 4.63) 2.88 (1.92 – 4.34) 5.16 (3.15 – 8.46) 
1 neither somatization nor health anxiety (N = 5788) as a common reference group 
2 somatic diagnosis and drugs taken for any somatic condition 
3 continuous variables 
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Figure 1. The shape of the association between levels of health anxiety and disability pension award during 1.0 
to 6.6 years follow-up (N = 6819) 
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Table 5. Comparison of causes of disability pension award in persons with and without health anxiety (case-level 
>= 95th percentile) at baseline1 (N = 215) 
 
Official primary diagnosis 
for which disability 
pension was awarded  
Health anxiety  
< 95 percentile 
 (N = 178)  
 
N (%) 95% CI 
Hypochondriasis score  
>= 95 percentile 
(N = 37) 
 
N (%) 95% CI 
Psychiatric disorders 
(ICD F00 – F99)  
36 (20.2) 14.3 – 26.1 14 (37.8) 22.2 – 53.5  
Musculoskeletal disorders 
(ICD M00 – M99)  
87 (48.9) 41.5 – 56.2 14 (37.8) 22.5 – 53.5 
Other causes (any other 
ICD code)  
55 (30.9) 24.1 – 37.7 9 (24.3) 10.5 – 38.1 
1  Chi-sq=5.326, df=2, p=.070 
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Table 6. Comparison of effects of health anxiety, HADS anxiety and HADS depression (all continuous variables 
z-scaled scores) on risk of disability pension award (N = 6819) 
 
Adjustment variables Predictor:  
Health anxiety 
(N = 227 awards) 1 
Predictor:  
HADS general anxiety 
(N = 227 awards) 1 
Predictor:  
HADS depression 
(N = 227 awards) 1 
  
OR 
 
 
95% CI 
 
OR 
 
95% CI 
 
OR 
 
95% CI 
Crude  1.76 1.60 – 1.94 1.55 1.38 – 1.74 1.58 1.42 – 1.76 
+ Gender  1.76 1.60 – 1.94 1.50 1.34 – 1.69 1.63 1.46 – 1.81 
+ Income and education 1.66 1.50 – 1.83 1.41 1.26 – 1.59 1.51 1.35 – 1.69 
+ Somatic Conditions2 1.64 1.48 – 1.81 1.39 1.24 – 1.57 1.50 1.35 – 1.68 
+ Somatic symptoms 1.37 1.21 – 1.54 1.06 0.92 – 1.22 1.25 1.11 – 1.42 
+ HADS general anxiety3  1.41 1.24 – 1.61 - - 1.32 1.14 – 1.53 
+ Health anxiety3 - - 0.91 0.78 – 1.07 1.26 1.08 – 1.46 
+ HADS depression3 1.37 1.20 – 1.57 0.81 0.68 – 0.96 - - 
1 N = 6592 not awarded disability pension during follow-up (1.0 to 6.6 years) as a common reference group  
2 somatic diagnosis and drugs taken for any somatic condition 
3 continuous variables 
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Table 7. Principal component analysis of the Whiteley Index and the effect of each factor (continuous z-scaled 
score) on risk of disability pension award (N = 6819) 
 
Whiteley Index item Bodily 
preoccupation1 
  Disease 
phobia1 
Disease 
conviction1 
2 Are you bothered by many aches and pains? 
4 Do you worry a lot about your health? 
5 Do you often have the symptoms of very serious illnesses? 
8 Do you find that you are bothered by many different 
symptoms? 
13 Do you think there is something seriously wrong with 
your body? 
 
0.73 
0.72 
0.68 
0.64 
 
0.53 
- 
0.36 
0.28 
0.33 
 
0.49 
0.21 
0.11 
0.19 
- 
 
0.13 
1 Do you often worry about the possibility that you have got 
a serious illness? 
3 Do you find that you are often aware of various things 
happening in your body? 
6 If a disease is brought to your attention (through the radio, 
television, newspapers or someone you know) do you worry 
about getting it yourself? 
12 Do you think that you worry about your health more than 
most people? 
14 Are you afraid of illness? 
 
0.13 
 
- 
 
0.41 
 
 
0.36 
 
0.36 
0.78 
 
0.75 
 
0.70 
 
 
0.60 
 
0.43 
0.11 
 
0.17 
 
- 
 
 
0.25 
 
0.15 
7 If you feel ill and someone tells you that you are looking 
better, do you become annoyed? 
9 Is it easy for you to forget about yourself and think about 
all sorts of other things? 
10 Is it hard for you to believe the doctor when he tells you 
there is nothing for you to worry about? 
11 Do you get the feeling that people are not taking your 
illness seriously enough? 
 
- 
 
0.50 
 
0.19 
 
0.42 
0.11 
 
- 
 
0.27 
 
0.22 
0.82 
 
0.58 
 
0.49 
 
0.47 
Eigenvalue 3.10 2.91 1.71 
Explained Variance 22% 21% 12% 
Effect on disability pension award (N = 277 awards)2 
 
Crude 
 
+ Gender 
OR (95% CI) 
 
2.03  
(1.83 – 2.26) 
2.06  
(1.85 – 2.29) 
OR (95% CI) 
 
0.87 
 (0.74 – 1.02) 
0.87 
 (0.74 – 1.01) 
OR (95% CI) 
 
1.45 
 (1.30 – 1.62) 
1.44  
(1.29 – 1.60) 
1 Values below .10 are not reported 
2 N = 6655 not awarded disability pension during follow-up (1.0 to 6.6 years) as reference group 
 
 
